Corbevax gets DCGI nod for use as booster jab{br} https://ift.tt/uLUz4W8

Hyderabad-based Biological E Limited’s Covid-19 vaccine Corbevax has emerged as the first vaccine to bag approval from the Drug Controller General of India for use as a heterologous booster dose, for those aged 18 years and above, after 6 months of administration of the second dose of either Covaxin or Covishield.

from Times of India https://ift.tt/dNMwzTC

Comments

Popular posts from this blog

रिश्तों को सुधारने की पहल:इस पर जोर कि कश्मीर ही नहीं, कारोबार पर भी बात हो; भारत को मध्य एशिया तक व्यापार मार्ग दे सकता है पाक (br) https://ift.tt/eA8V8J